Retraction notice to “Corrigendum to ‘Aptamer/doxorubicin-conjugated nanoparticles target membranous CEMIP2 in colorectal cancer’ [International Journal of Biological Macromolecules 248 (2023) 125782]” (International Journal of Biological Macromolecules (2023) 248, (S0141813023026776), (10.1016/j.ijbiomac.2023.125782))
International Journal of Biological Macromolecules
Volume
293
Rights Holder(s)
SCOPUS
Bibliographic Citation
International Journal of Biological Macromolecules Vol.293 (2025)
Suggested Citation
Kianpour M., Huang C.W., Vejvisithsakul P.P., Wang J.Y., Li C.F., Shiao M.S., Pan C.T., Shiue Y.L. Retraction notice to “Corrigendum to ‘Aptamer/doxorubicin-conjugated nanoparticles target membranous CEMIP2 in colorectal cancer’ [International Journal of Biological Macromolecules 248 (2023) 125782]” (International Journal of Biological Macromolecules (2023) 248, (S0141813023026776), (10.1016/j.ijbiomac.2023.125782)). International Journal of Biological Macromolecules Vol.293 (2025). doi:10.1016/j.ijbiomac.2024.138913 Retrieved from: https://repository.li.mahidol.ac.th/handle/20.500.14594/102760
Title
Retraction notice to “Corrigendum to ‘Aptamer/doxorubicin-conjugated nanoparticles target membranous CEMIP2 in colorectal cancer’ [International Journal of Biological Macromolecules 248 (2023) 125782]” (International Journal of Biological Macromolecules (2023) 248, (S0141813023026776), (10.1016/j.ijbiomac.2023.125782))
This article has been retracted: please see Elsevier Policy on Article Withdrawal (https://www.elsevier.com/locate/withdrawalpolicy). This corrigendum has been retracted at the request of the corresponding authors and the Editor-in-Chief. This corrigendum is being retracted because the article that it corrected has been retracted.
We collect and process your personal information for the following purposes: Authentication, Preferences, Acknowledgement and Statistics. To learn more, please read our privacy policy.
